Neurotonix is a neurotherapy company that specializes in the development of products for the treatment of neurodegenerative diseases. The company's flagship product, Neurotonix, is an advanced neurostimulation system for use in patients with Alzheimer's disease, Parkinson's disease and other diseases.

The Neurotonix technology is based on a platform that uses electrical current to direct stem cells to repair damaged tissue and restore function. The system is designed to provide relief from chronic pain without causing side effects like nausea or vomiting.

Neurotonix has been used successfully on more than 20 patients with Alzheimer's disease at its clinical trial sites in the United States and Europe. A Phase II clinical trial is currently underway at UCLA Medical Center to evaluate safety and efficacy of Neurotonix therapy for people with mild to moderate Alzheimer's disease as well as for those who have been diagnosed as having mild cognitive impairment (MCI).

https://www.tribuneindia.com/news/brand-connect/neurotonix-reviews-2023-shocking-customer-update-scam-pills-or-real-neurotonix-ingredients-467045